Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices. Clin Lipidol 2009 Feb;4(1):113-124

Date

02/01/2009

Pubmed ID

20582235

Pubmed Central ID

PMC2891274

DOI

10.2217/17584299.4.1.113

Scopus ID

2-s2.0-67149105628 (requires institutional sign-in at Scopus site)   59 Citations

Abstract

Lecithin:cholesterol acyltransferase (LCAT) is an enzyme that first hydrolyzes the sn-2 position of phospholipids, preferentially a diacylphosphocholine, and then transfers the fatty acid to cholesterol to yield a cholesteryl ester. HDL ApoA-I is the principal catalytic activator for LCAT. Activity of LCAT on nascent or lipid-poor HDL particles composed of phospholipid, cholesterol and ApoA-I allows the maturation of HDL particles into lipid-rich spherical particles that contain a core of cholesteryl ester surrounded by phospholipid and ApoA-I on the surface. This article reviews the recent progress in elucidating structural aspects of the interaction between LCAT and ApoA-I. In the last decade, there has been considerable progress in understanding the structure of ApoA-I and the central helices 5, 6, and 7 that are known to activate LCAT. However, much less information has been forthcoming describing the 3D structure and conformation of LCAT required to catalyze two separate reactions within a single monomeric peptide.

Author List

Sorci-Thomas MG, Bhat S, Thomas MJ

Authors

Mary Sorci Thomas PhD Professor in the Medicine department at Medical College of Wisconsin
Michael J. Thomas PhD Professor in the Pharmacology and Toxicology department at Medical College of Wisconsin